We are initiating coverage of IR-Med, Inc. (OTC:IRME), a development stage medical device company that is creating a technology platform for non-invasive devices to be used as a decision support ...

On February 20, 2024, the IR-Med (OTC:IRME) announced highly favorable proof of efficacy data for PressureSafe, its decision support device which uses infra-red spectroscopy combined with an AI-based ...

IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company’s development products pipeline consists of PressureSafe, a ...

IR-Med Inc. (IRME) growth grade and underlying metrics. Quant Ratings, revenue growth, EBITDA, EPS, cash flow, ROE, compounded, charts, and stocks comparison.

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...